pt141 Bremelanotide (PT-141) Nasal Spray PT-141 Nasal Spray (Bremelanotide) 40mg,

(Any extended room-temperature exposure degrades potency) 4

Nissl staining and TUNEL staining Mice were sacrificed was measured at 48 h post-TBI and brains were carefully extracted and fixed in a 4% paraformaldehyde solution for 6 h

Behavioral flexibility in a mouse model of developmental cerebellar purkinje cell loss

Excess body weight and insulin resistance are linked to higher baseline levels through fatty liver changes

Injection volumes below 0.5mL are well-tolerated subcutaneously, so there is rarely a clinical need to exceed 1.5mg/mL concentration unless your protocol requires exceptionally high per-dose quantities